New paradigm of gene therapy: skeletal-muscle-targeting gene therapy for kidney disease.
Imai
E
E
Division of Nephrology, Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan. kidney@medone.med.osaka-u.ac.jp
Isaka
Y
Y
D000818:Animals; D004274:DNA, Recombinant / Q000008:administration & dosage / Q000235:genetics; D000229:Dependovirus / Q000235:genetics; D018274:Electroporation; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D017228:Hepatocyte Growth Factor / Q000235:genetics; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy*; D008081:Liposomes; D018482:Muscle, Skeletal / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D018108:Respirovirus / Q000235:genetics; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000235:genetics
D004274:DNA, Recombinant; D008081:Liposomes; D016212:Transforming Growth Factor beta; D017228:Hepatocyte Growth Factor